OK, I see where you are coming from now, and please believe me lasers, I am not fabricating my information about speaking with ASGCT and with the information they told me. I realize our discussion did evolve into an argument and I apologize for my hand in that. I would really like to get all this figured out so here are my thoughts. Is it not possible, that they are presenting the melanoma Phase 1 and 2 at ASGCT, because they were invited, as it was not an abstract they submitted they can present whatever they choose based on their agreement with the ASGCT invitation and as this would not fall under ASGCT abstract policies. So they could present the data and discuss the expansion trial. Again, this is all under the premise of the information given that ONCS did not submit an abstract but was invited.
From here you do bring up the point of when ONCS will make a formal statement about this event, if the event is a data presentation. Just speculating, but is it not possible they intend to but just have not. This is scheduled for May 22.
Again, my apologies for the argument, I would very much like to continue this as a discussion.
News 
Market Data 
Discover 
AI
